The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analysis

The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analysis

他のバージョン（1件）を表示する

**Background:** There are sparse data addressing whether standard risk factors for febrile neutropenia (FN) are relevant in patients receiving myelosuppressive chemotherapy and primary prophylaxis for FN, which would have implications for variables to consider during real-world comparative analyses...

書誌詳細
主要な著者:	Edward Li, Bridgette Kanz Schroader, David Campbell, Kim Campbell, Weijia Wang
フォーマット:	論文
言語:	English
出版事項:	Columbia Data Analytics, LLC 2021-06-01
シリーズ:	Journal of Health Economics and Outcomes Research
オンライン･アクセス:	https://jheor.scholasticahq.com/article/24564-the-impact-of-baseline-risk-factors-on-the-incidence-of-febrile-neutropenia-in-breast-cancer-patients-receiving-chemotherapy-with-pegfilgrastim-prophy.pdf

類似資料

The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analysis
著者:: Edward Li, 等
出版事項: (2021-06-01)

Prophylaxis against febrile neutropenia with pegfilgrastim in Italy: a budget impact analysis
著者:: Giovanni Rosti, 等
出版事項: (2011-09-01)

On-body injector pegfilgrastim for chemotherapy-induced neutropenia prophylaxis: Current Status
著者:: Ivo Abraham, 等
出版事項: (2024-01-01)

Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy
著者:: Patrizia Berto, 等
出版事項: (2022-02-01)

Incidence and Impact of Baseline Electrolyte Abnormalities in Patients Admitted with Chemotherapy Induced Febrile Neutropenia
著者:: Asim Jamal Shaikh, Samira Ahmed Bawany, Nehal Masood, Ausaf Ahmed Khan, Ahmed Nadeem Abbasi, Syed Najeeb Niamutullah, Adnan Zaidi, Salman Adil, Shiyam Kumar
出版事項: (2011-01-01)

Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review
著者:: Girma Tekle Gebremariam, 等
出版事項: (2022-12-01)

An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer
著者:: Anbok Lee, 等
出版事項: (2023-12-01)

Pegfilgrastim on febrile neutropenia in pediatric and adolescent cancer patients: a systematic review and meta-analysis
著者:: Xia Zhu, 等
出版事項: (2023-12-01)

Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience
著者:: Shinya Tsuboi, 等
出版事項: (2023-01-01)

Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study
著者:: Youngwoo Jeon, 等
出版事項: (2023-03-01)

Prophylaxis and management of chemotherapy-induced febrile neutropenia: The role of myeloid growth factors
著者:: Dimitrijević Jelena, 等
出版事項: (2022-01-01)

Correction to: Higher incidence of pegfilgrastim-induced bone pain in younger patients receiving myelosuppressive chemotherapy: a real-world experience
著者:: Shinya Tsuboi, 等
出版事項: (2023-04-01)

CHEMOTHERAPY-INDUCED NEUTROPENIA IN HIV POSITIVE PATIENTS WITH LYMPHOMA: COMPARISON OF PEGFILGRASTIM WITH DAILY FILGRASTIM ADMINISTRATION.
著者:: Luciana Teofili, 等
出版事項: (2012-01-01)

CHEMOTHERAPY-INDUCED NEUTROPENIA IN HIV POSITIVE PATIENTS WITH LYMPHOMA: COMPARISON OF PEGFILGRASTIM WITH DAILY FILGRASTIM ADMINISTRATION.
著者:: Luciana Teofili, 等
出版事項: (2012-10-01)

Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy
著者:: Zsuzsanna Kahan, 等
出版事項: (2019-02-01)

Identifying Risk Factors and Improving Preventive Strategies for Febrile Neutropenia in Children with Leukemia Receiving Ciprofloxacin Prophylaxis
著者:: Zühre Kaya, 等
出版事項: (2023-08-01)

NEUTROPENIA FEBRIL EN PEDIATRIA Febrile Neutropenia in Pedriatrics
著者:: Pio Lopez, 等
出版事項: (2008-03-01)

Prophylactic pegfilgrastim reduces febrile neutropenia in ramucirumab plus docetaxel after chemoimmunotherapy in advanced NSCLC: post hoc analysis from NEJ051
著者:: Keita Miura, 等
出版事項: (2024-02-01)

XM02 is superior to placebo and equivalent to Neupogen™ in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy
著者:: Topuzov E, 等
出版事項: (2008-11-01)

Febrile neutropenia recurrence after chemotherapy in patients with breast cancer
著者:: Simone Yuriko Kameo, Glebson Moura Silva, Namie Okino Sawada, Mary Elizabeth de Santana
出版事項: (2020-10-01)

Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
著者:: Federica Cennamo, 等
出版事項: (2021-11-01)

Evaluation of Febrile Neutropenia in Hospitalized Patients with Neoplasia Undergoing Chemotherapy
著者:: Maria Bachlitzanaki, 等
出版事項: (2023-10-01)

Bloodstream infection in pediatric patients with febrile neutropenia induced by chemotherapy
著者:: Mariana Antunes Faria Lima, 等
出版事項: (2023-04-01)

Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update
著者:: Paola Villafuerte-Gutierrez, 等
出版事項: (2014-01-01)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
著者:: Doaa Naeem, 等
出版事項: (2018-08-01)

Knowledge, attitude and practice towards chemotherapy-related neutropenia and febrile neutropenia among breast cancer patients
著者:: Yilin Chen, 等
出版事項: (2024-10-01)

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey [Corrigendum]
著者:: Innocenti R, 等
出版事項: (2019-02-01)

Respiratory distress and sudden death of a patient with GSDIb chronic neutropenia: possible role of pegfilgrastim
著者:: Jean Donadieu, 等
出版事項: (2009-08-01)

Uso do dispositivo Pegfilgrastim OBI para prevenção de neutropenia: revisão de escopo
著者:: Vivian do Prado Martins, 等
出版事項: (2023-08-01)

Corrigendum to “Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update”
著者:: Paola Villafuerte-Gutierrez, 等
出版事項: (2019-01-01)

Fluoroquinolone Prophylaxis Against Febrile Neutropenia in Areas With High Fluoroquinolone Resistance—An Asian Perspective
著者:: Esther Shu-Ting Ng, 等
出版事項: (2010-09-01)

Incidence of chemotherapy-induced neutropenia in HIV-infected and uninfected patients with breast cancer receiving neoadjuvant chemotherapy
著者:: Ngidi, S, 等
出版事項: (2017)

A comparison of eflapegrastim to pegfilgrastim in the management of chemotherapy‐induced neutropenia in patients with early‐stage breast cancer undergoing cytotoxic chemotherapy (RECOVER): A Phase 3 study
著者:: Patrick Wayne Cobb, 等
出版事項: (2020-09-01)

Low albumin at the onset of febrile neutropenia predicts adverse outcome in pediatric febrile neutropenia
著者:: Manideepa Maji, 等
出版事項: (2022-01-01)

Level of Knowledge and Incidence of Emergency Oncology: Febrile Neutropenia in Hematologic Cancer Patients Post Chemotherapy: A Descriptive Study
著者:: Agus Suryaman
出版事項: (2024-12-01)

Tratamiento ambulatorio del paciente con neutropenia febril Outpatient therapy in patients with febrile neutropenia
著者:: Andrés Londoño Gallo
出版事項: (2008-01-01)

Predictive value of peri-chemotherapy hematological parameters for febrile neutropenia in patients with cancer
著者:: Hongyuan Jia, 等
出版事項: (2024-08-01)

Comparison of CISNE and MASCC Score in Predicting Complications on Post Chemotherapy Febrile Neutropenia
著者:: Sharifah Shakinah, 等
出版事項: (2024-07-01)

Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
著者:: José C. Álvarez, 等
出版事項: (2021-04-01)

Outcomes in 102 patients that present to the emergency department with chemotherapy-induced febrile neutropenia
著者:: Joo Han Lim, 等
出版事項: (2011-08-01)